Friday, December 26, 2025
ADVT 
Health

How genes affect Ebola patients

Darpan News Desk IANS, 31 Oct, 2014 08:14 AM
    New York- The Ebola virus affects different people differently, say researchers, adding that genetic factors could be behind this mild-to-deadly range of reactions to the virus.
     
    While some people completely resist the disease, others suffer moderate to severe illness and recover, while those who are most susceptible succumb to bleeding, organ failure and shock.
     
    These differences are not related to any specific changes in the Ebola virus itself; instead, the body's attempts to fight infection seems to determine disease severity.
     
    "Our data suggest that genetic factors play a significant role in disease outcome," said Michael Katze from University of Washington.
     
    For the study, the researchers examined the role of an individual's genetic makeup in the course of Ebola disease through a mouse model.
     
    The researchers had obtained genetically diverse group of inbred laboratory mice to study locations on mouse genomes associated with influenza severity.
     
    The scientists examined mice that they infected with a mouse form of the same species of Ebola virus causing the 2014 West Africa outbreak.
     
    The scientists found that disease outcomes and variations in mortality rates were co-related to specific genetic lines of mice.
     
    "The frequency of different manifestations of the disease across the lines of these mice screened so far are similar in variety and proportion to the spectrum of clinical disease observed in the 2014 West African outbreak," co-lead researcher Angela Rasmussen from University of Washington pointed out.
     
    Survivors experienced more activity in genes that order blood vessel repair and the production of infection-fighting white blood cells.
     
    The scientists noted that certain specialised types of cells in the liver could also have limited virus reproduction and put a dampener on systemic inflammation and blood clotting problems in resistant mice.
     
    "We hope that medical researchers will be able to rapidly apply these findings to candidate therapeutics and vaccines," Katze stressed.
     
    The study appeared in the journal Science.

    MORE Health ARTICLES

    Herbal anti-malaria drug may control asthma

    Herbal anti-malaria drug may control asthma
    According to researchers from National University of Singapore (NUS), the "artesunate" herbal drug can herald better treatment outcomes than other...

    Herbal anti-malaria drug may control asthma

    Probiotics crucial for super gut health

    Probiotics crucial for super gut health
    The bacteria that aid in digestion help keep the intestinal lining intact, scientists say, adding that daily probiotics hold the key to ward off inflammatory...

    Probiotics crucial for super gut health

    Watch your waistline for diabetes risk

    Watch your waistline for diabetes risk
    A British health report has warned that adults with a large waistline are five times more likely to develop type 2 diabetes....

    Watch your waistline for diabetes risk

    Way to restore body's insulin producing ability

    Way to restore body's insulin producing ability
    There is good news for patients suffering from type-one diabetes as they may soon be able to do away with their daily insulin dose to manage their blood-sugar levels...

    Way to restore body's insulin producing ability

    Starvation genes run in families

    Starvation genes run in families
    If your ancestors have faced starvation at some point of time, chances are that you may also have inherited the "memory of starvation" and can pass this to future generations....

    Starvation genes run in families

    New treatment for gum disease in diabetics

    New treatment for gum disease in diabetics
    Going to the dentist may not be fun but for those with periodontal disease related to type-two diabetes, a new research may bring back their smile....

    New treatment for gum disease in diabetics